China (Mainland)
Premiumsupplier
99%min Imatinib Mesylate 220127-57-1 CAS NO.220127-57-1
- Min.Order: 10 Gram
- Payment Terms: T/T,MoneyGram
- Product Details
Keywords
- 99%min Imatinib Mesylate
- Imatinib Mesylate Manufacturer
- For Treatment Of Leukemia
Quick Details
- ProName: 99%min Imatinib Mesylate 220127-57-1
- CasNo: 220127-57-1
- Molecular Formula: C30H35N7O4S
- Appearance: White Powder
- Application: For Pharmaceutical Raw Materials
- DeliveryTime: 2-4 days after confirmed your payments
- PackAge: 100g/ bag, 2 kg/ bag, 25kg/ carton or ...
- Port: ShangHai
- ProductionCapacity: 1000 Metric Ton/Month
- Purity: 99%min
- Storage: Dry and cool place
- Transportation: By DHL, TNT, FedEx, HKEMS, UPS, Etc
- LimitNum: 10 Gram
Superiority
Advantages:
Hubei XinRunde Chemical Co., Ltd is a renowned pharmaceutical manufacturer. We can offer high quality products at competitive price in quick delivery with 100% custom pass guaranteed. Never stop striving to offer our best service is our philosophy. We have Flexible and Untraceable payment terms. As a leading manufacture, our products have been exported to Germany, Norway, Poland, Finland, Spain, UK, France, Russia, USA, Brazil, Mexico, Australia, Japan, Korea, Thailand, Indonesia, Uruguay and many other countries.
1. Quality.Every batch of steroid powders have tobetested by our QC(quality control) before they are allowed to sell.
2 . Delivery We have stock, so we can delivery quickly at the very day when receive the payment. Within 24 hours after receiving the payment Lead time 4 or 7 days.
3 . Discreet package Safelyand Professionally Disguised Package Guaranteed. For your safety and to insure delivery all products will be packed in a discreet way to prevent any suspicions, no steroids related name will appear on the parcels. high successful delivery rate
4 . Warm after-sale service Any of your question would be solved for the first as soon as possible.
Details
| Imatinib mesylate Basic information |
| Product Name: | Imatinib mesylate |
| Synonyms: | 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;STI-571;IMATINIB BASE(IMA-3);ImatinibMesylate/Gleevec;Imatinib Methanesulfonate, STI-571, CGP-57148B, Glivec,;IMATINIB MESYLATE (IMATINIB METHANESULFONATE);alpha-IMATINIB MESYLATE;Imatinib mesylate(TINIBS ) |
| CAS: | 220127-57-1 |
| MF: | C30H35N7O4S |
| MW: | 589.71 |
| EINECS: | 1308068-626-2 |
| Product Categories: | Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Pharmaceuticals;Tyrosine Kinase Inhibitors;Aromatics;Heterocycles;API;Glivec, CGP-57148B, STI-571;Antineoplastic;Anti-cancer&immunity;Inhibitors;Anticancer |
| Mol File: | 220127-57-1.mol |
|
|
|
| Imatinib mesylate Chemical Properties |
| Melting point | 214-224°C |
| storage temp. | -20°C Freezer |
| solubility | H2O: soluble10mg/mL, clear |
| color | white to beige |
| CAS DataBase Reference | 220127-57-1(CAS DataBase Reference) |
| Safety Information |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RTECS | CV5520550 |
| Hazardous Substances Data | 220127-57-1(Hazardous Substances Data) |
| Imatinib mesylate Usage And Synthesis |
| a small-molecule inhibitor |
Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia. As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans. |
| Chemical Properties | Off-White Solid |
| Uses | A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL) |
| Uses | Imatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. Imatinib also known as Gleevec, Glivec, CGP-57148B, STI-571 & Imatinib |
| Uses | Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. |
| Uses | echinocandin antifungal, active against infections with Aspergillus and Candida, inhibits cell wall synthesis |
| Definition | ChEBI: A methanesulfonate (mesylate) salt that is the monomesylate salt of imatinib. Used for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours. |